FdaApplication

ANDA 209714

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHBT LABS INC
application_typeANDA
approval_date2019-11-21

Products (1)

ProductActive ingredientStrengthDosage form
FULVESTRANTFULVESTRANT250MG/5ML (50MG/ML)SOLUTION;INTRAMUSCULAR

1 product